Synthes today announced its First Half Year 2008 financial results, with sales and earnings growth of 18.1% and 23.6%, respectively (12.6% and 16.9%, respectively, in local currencies).

UnitedHealth on Wednesday cut its outlook for fiscal 2008 but the health insurance giant also said it was cutting costs, a move that sent shares higher and seemed to give a lift to the rest of the sector.

Symmetry Medical Inc. a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced first quarter 2008 financial results for the period ended March 29, 2008.

Shares of Tenet Healthcare Corp. jumped after an analyst upgraded the stock. Since late 2007, Tenet has signed new contracts with health insurers including Cigna Corp., Aetna Inc. and UnitedHealth Group Inc., giving patients covered by those insurers access to Tenet's hospitals.

Shares of Cardinal Health ended trading higher by more than 6% after the drug distributor reported third-quarter earnings that exceeded analyst views, thanks to repricing of large retail accounts and the renewal of anti-diversion efforts.

Hill-Rom Holdings, Inc. reporting for the first time since the spin-off of the funeral services business, announced unaudited financial results for its fiscal second quater ended March 31, 2008.  Results included revenue of $375.2 million, a $40.2% million or 12.0 percent increasw from $335.0 milicon in the prior year comparable period.

Coventry Health Care Inc. net income ticked nearly 3% higher in the first quarter, enabling the health insurer's shares to make gains.   The Bethesda, Md.-based company  reported a profit of $125 million, or 81 cents a share, up from $121.7 million, or 76 cents, earned in the year-earlier first quarter.

Shares of Wright Medical Group Inc jumped by as much as 27 percent on  Friday, 25th April' 08 after the orthopedic device company posted better-than-expected quarterly results, prompting at least one broker upgrade.

Fisher and Paykel Healthcare have fallen nearly four per cent after the company cut its full-year operating profit forecast by 16 per cent, citing the strong New Zealand dollar.

Exelixis Inc has announced that Genentech Inc  has exercised the option to further develop and market Exelixis' experimental cancer drug XL518, which is currently in an early stage trial.

Reports on the growing Chinese healthcare market opportunities, with focus on featured company, Benda Pharmaceutical Inc.

With a shared vision of a more personalized medicine, Siemens Healthcare and National Jewish Medical and Research Center, based at Denver in US have formed a strategic alliance to improve and develop novel imaging and diagnostic technologies using genomics, proteomics, and integrated research and clinical care.

This Frost & Sullivan research service entitled European Markets for Healthcare IT Platforms provides anoverview of the market dynamics and revenues, along with a complete analysis of key drivers, restraints, and trends in Germany, France, the United Kingdom, Italy, Spain, Scandinavia and Benelux. In this research service, Frost & Sullivan's expert analysts thoroughly examine the   following: clinical information systems and administrative information systems.

The UK private healthcare market has emerged and evolved in the shadow of the most comprehensive public healthcare system in the developed world — the NHS. Traditionally, the private sector was   formed to complement, rather than compete with, the NHS by allowing patients to avoid waiting lists  for elective surgery.

Kalorama's Best Selling Medical Tech title and one of several overall best sellers of 2007.Wireless technologies and healthcare are a perfect fit. The clinical environment is a highly mobile one, and physicians, nurses and other clinical operators have a real need for fast information and action.

The government has relied on simple P&R tools to contain rising healthcare costs and provide a  reasonable level of healthcare.

Telehealth has the potential to change the delivery of healthcare but as an emerging technology, it  faces multiple challenges to widespread adoption. This report provides an in-depth analysis of this  emerging market.

While insurance is the most common form of payment for healthcare services, increasingly   customers are paying for their own expenses. Pharmaceutical, device and diagnostic companies,   should recognize that a part of their revenues are originating directly or indirectly from out of pocket   expenditures.